Reaction

Hernia Repair reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,553 reports · 49 co-occurring drugs

As of the last recalculation, Hernia Repair appears in 2,553 FAERS reports alongside 49 co-occurring drug terms. The strongest observed disproportionality signal is NIRAPARIB (PRR 17.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Niraparib	46	17.2	17.2
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	13	12.0	12.1
Bosentan	68	11.3	11.3
Relugolix	27	9.4	9.4
Epoprostenol	15	9.4	9.4
Bimekizumab	23	8.9	8.9
Macitentan	57	6.8	6.8
Selexipag	20	6.4	6.4
Sildenafil Powder,	27	6.2	6.2
Fluticasone Propionate And Salmeterol	29	5.7	5.7
Sitagliptin And Metformin Hydrochloride	15	5.7	5.7
Finasteride	41	5.6	5.6
Rucaparib	6	5.6	5.6
Riociguat	22	5.5	5.5
Armodafinil	14	5.4	5.4
Sodium Oxybate	39	4.9	4.9
Sildenafil	34	4.8	4.8
Mepolizumab	28	4.6	4.6
Certolizumab Pegol	65	4.6	4.6
Tolvaptan	8	4.5	4.5
Eptinezumab-Jjmr	5	4.5	4.5
Etonogestrel And Ethinyl Estradiol	12	4.4	4.4
Sildenafil Citrate	63	4.1	4.1
Oral Semaglutide	36	4.0	4.0
Calcium, Magnesium, Potassium, And Sodium Oxybates	4	3.8	3.8
Ixekizumab	17	3.8	3.8
Vilazodone Hydrochloride	4	3.5	3.5
Umeclidinium Bromide And Vilanterol Trifenatate	7	3.4	3.4
Teriparatide	45	3.3	3.3
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	16	3.2	3.2
Rifaximin	8	3.1	3.1
Trifluridine And Tipiracil	4	3.0	3.0
Abiraterone	5	3.0	3.0
Interferon Beta-1B	7	3.0	3.0
Patiromer	5	2.9	2.9
Lumacaftor And Ivacaftor	3	2.9	2.9
Hydrocodone Bitartrate And Acetaminophen	18	2.6	2.6
Velpatasvir And Sofosbuvir	4	2.5	2.5
Exenatide	15	2.3	2.3
Droxidopa	6	2.3	2.3
Tafamidis	3	2.1	2.1
Pirfenidone	9	1.8	1.8
Pimavanserin Tartrate	12	1.8	1.8
Ledipasvir And Sofosbuvir	4	1.7	1.7
Dornase Alfa	4	1.7	1.7
Dupilumab	86	1.5	1.5
Apremilast	21	1.2	1.2
Evolocumab	23	1.2	1.2
Copper	3	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.